<!DOCTYPE html>
<html lang="en">
    <head>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
        <meta name="description" content="" />
        <meta name="author" content="" />
        <title>CDSS - An Overview</title>
        <link rel="icon" type="image/x-icon" href="assets/img/favicon.ico" />
        <!-- Font Awesome icons (free version)-->
        <script src="https://use.fontawesome.com/releases/v5.15.4/js/all.js" crossorigin="anonymous"></script>
        <!-- Google fonts-->
        <link href="https://fonts.googleapis.com/css?family=Saira+Extra+Condensed:500,700" rel="stylesheet" type="text/css" />
        <link href="https://fonts.googleapis.com/css?family=Muli:400,400i,800,800i" rel="stylesheet" type="text/css" />
        <!-- Core theme CSS (includes Bootstrap)-->
        <link href="css/styles.css" rel="stylesheet" />
    </head>
    <body id="page-top">
        <!-- Navigation-->
        <nav class="navbar navbar-expand-lg navbar-dark bg-primary fixed-top" id="sideNav">
            <a class="navbar-brand js-scroll-trigger" href="/virtual-greenhouse-project/index.html">
                <span class="d-block d-lg-none">Virtual Greenhouse</span>
                <span class="d-none d-lg-block"><img class="img-profile rounded-circle mx-auto mb-2" src="/virtual-greenhouse-project/assets/img/icon.jpg" alt="..." /><br><br>Virtual Greenhouse</span>
            </a>
            <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarResponsive" aria-controls="navbarResponsive" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button>
            <div class="collapse navbar-collapse" id="navbarResponsive">
                <ul class="navbar-nav">
                    <li class="nav-item"><a class="nav-link js-scroll-trigger" href="/virtual-greenhouse-project/index.html">About</a></li>
                    <li class="nav-item"><a class="nav-link js-scroll-trigger" style="color:white;" href="/virtual-greenhouse-project/parameters.html">Real-time parameters</a></li>
                    <li class="nav-item"><a class="nav-link js-scroll-trigger" href="/virtual-greenhouse-project/alerts.html">Alerts</a></li>
                </ul>
            </div>
        </nav>
        <!-- Page Content-->
        <div class="container-fluid p-0">
            <!-- All-->
            <section class="resume-section" id="experience">
                <div class="resume-section-content">
                    <h2 class="mb-5">All Reviewed Clinical Decision SUpport Systems:</h2>
                    <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/1_navify.html">NAVIFY Mutation Profiler</a></h3>
                            <div class="subheading mb-3">Made by Roche</div>
                            <p>NAVIFY Mutation Profiler is CE-IVD-certified software that helps interpret
clinically important, detected variants, e.g., disease-associated
variant instances, broader variant groups, variant combinations, and
variants of unknown significance, acquired by NGS testing.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://www.navify.com/products/navify-mutation-profiler/">webpage</a></span></div>
                    </div>
                    <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/2_wfo.html">WATSON FOR ONCOLOGY</a></h3>
                            <div class="subheading mb-3">Made by IBM</div>
                            <p> Watson for Oncology (WFO) looks for traits
in patients’ EHRs, genetic information, and operability status to find
suitable treatment plans. It then uses machine learning and natural language
processing techniques to process text documents and identify
literature matching the patients’ characteristics. As an output, WFO produces ranked recommendations, such as
anticancer drugs, their combinations, and radiation and hormone
therapies, with the associated NCCN guidelines and other evidence
to support the recommendations.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://www.ibm.com/watson-health/solutions">webpage</a></span></div>
                    </div>
                    <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/3_qiagen.html">QIAGEN Clinical Insight Interpret One</a></h3>
                            <div class="subheading mb-3">Made by QIAGEN Digital Insights</div>
                            <p>QIAGEN Clinical Insights is a commercial clinical decision
support tool portfolio that includes tools that translates molecular
data into therapy recommendations.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://digitalinsights.qiagen.com/products-overview/clinical-insights-portfolio/qiagen-clinical-insight/qci-interpret-one/#">webpage</a></span></div>
                    </div>
                    <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/4_oncopdss.html">Oncology Pharmacotherapy Decision Support System (OncoPDSS)</a></h3>
                            <div class="subheading mb-3">Made by the Cancer Precision Medicine group of the Bioinformatics Research Institute of National Enineering Research Center for Beijing Biochip Technology, China</div>
                            <p>Oncology Pharmacotherapy Decision Support System (OncoPDSS) is
a web server that can be used by researchers and clinicians alike, as it
serves as a knowledge base on cancer precision medicine. The evidence-based
CDSS helps clinicians with pharmacotherapy decision-making
by using actionable alterations associated with clinical implications to
interpret sequencing results accurately at the individual level.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://oncopdss.capitalbiobigdata.com/rest/pageForward">webpage</a></span></div>
                    </div>
                    <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/5_curematch.html">CureMatch</a></h3>
                            <div class="subheading mb-3">Made by CureMatch, Inc.</div>
                            <p>CureMatch Bionov is a HIPAA and GDPR-compliant web-based CDSS
platform focused on personalized medicine, which provides oncological
combination therapies based on entire molecular profiles. Cure-
Match also considers other patient characteristics besides molecular
data, for example, comorbidities, medical history, or previous treatment
lines.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://www.curematch.com">webpage</a></span></div>
                    </div>
                     <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/6_onkokb.html">OncoKB</a></h3>
                            <div class="subheading mb-3">Made by Memorial Sloan Kettering Cancer Center</div>
                            <p>Developed at the Memorial Sloan Kettering Cancer Center, OncoKB
is a precision oncology knowledge base. It comprises biological and
clinical data regarding the genetic mutations that occur in cancer.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://www.oncokb.org">webpage</a></span></div>
                    </div>
                     <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/7_CGI">Cancer Genome Interpreter</a></h3>
                            <div class="subheading mb-3">Made by Barcelona Biomedical Genomics Lab</div>
                            <p>Cancer Genome Interpreter is another platform for interpreting tumor alterations according
to their biological and clinical relevance. The system supports clinical
decision-making by annotating potential tumorigenic alterations and
their effect on treatment response in newly sequenced cancer genomes
based on various evidence levels.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://www.cancergenomeinterpreter.org/home">webpage</a></span></div>
                    </div>
                     <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/8_prostate.html">Prostate Cancer Survival Calculator According to Initial Treatment Modality</a></h3>
                            <div class="subheading mb-3">Made by The Department of Urology, Yonsei University College of Medicine & Selvas AI, Seoul</div>
                            <p>Prostate
Cancer Survival Calculator According to Initial Treatment Modality 
employs an artificial neural network model to predict
survival outcomes according to 5 routine initial treatment modalities: active surveillance, radical prostatectomy, radiation therapy with androgen deprivation therapy, radiation therapy without androgen deprivation therapy, and androgen deprivation therapy.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://scapcalculator.yuhs.ac">webpage</a></span></div>
                    </div>
                    <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/9_prorads.html">ProRaDS</a></h3>
                            <div class="subheading mb-3">Made by The D-Lab, Department of Precision Medicine, GROW—School for Oncology and
Developmental Biology, Maastricht University</div>
                            <p>  This relatively new CDSS developed in the Netherlands is focused on
helping oncologists select a patient-specific treatment from two standard
therapies—radical prostatectomy (RP) and external beam radiotherapy
(EBRT)—for low- to intermediate-risk patients diagnosed
with PC. The CDSS achieves this by calculating the quality-adjusted
life years (QALYs) after 20 years and the probability percentages of
the following outcomes for RP and EBRT treatments: erectile dysfunction at two years, rectal bleeding at three years, urinary incontinence at one year, and cancer free at five years.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://ai4cancer-ai.herokuapp.com/models-browser">webpage</a></span></div>
                    </div>
                    <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/10_desiree.html">The DESIREE Project</a></h3>
                            <div class="subheading mb-3">Made by Vicomtech (Spain), Arivis AG (Germany), Assistance Publique – Hôpitaux de Paris (France), Bilbomatica (Spain), ERESA (Spain), Fundación Onkologikoa (Spain), INSERM-LIMICS (France), Medical Innovation and Technology (Greece), Sistemas Genómicos (Spain), Houston Methodist Research Institute (USA) & Ulster University (UK)</div>
                            <p>The DESIREE Project, funded by The European Union, started in 2016
and was completed in July 2019. One of Desiree’s many goals was to
develop several tools focused on handling primary breast cancer. They
designed and validated a decision support
tool for the DESIREE platform to deliver three types of recommendations: guideline-based,
case-based, and experience-based.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="http://www.desiree-project.eu">webpage</a></span></div>
                    </div>
                    <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/11_predict.html">Predict: Breast Cancer</a></h3>
                            <div class="subheading mb-3">Made by The Winton Centre for Risk & Evidence Communication</div>
                            <p>Predict: Breast Cancer consists of prediction models that can be used
to help make informed decisions about treatment following surgery
for early invasive breast cancer. Based on
several patient parameters, it calculates the overall survival rates after
five, ten, and fifteen years based on the selected post-surgery treatment
plans. The treatment options included in the predictions are hormone
therapy, chemotherapy (second and third generation), trastuzumab, bisphosphonates, and combinations of the forenamed therapies.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://breast.predict.nhs.uk">webpage</a></span></div>
                    </div>
                    <div class="d-flex flex-column flex-md-row justify-content-between mb-5">
                        <div class="flex-grow-1">
                            <h3 class="mb-0"><a class="nav-link js-scroll-trigger" href="/CDSS-overview/all/12_correct.html">corRECTreatment</a></h3>
                            <div class="subheading mb-3">Made by Department of Medical Informatics - Dokuz Eylül University and Department of Biostatistics and Medical informatics - Ege University</div>
                            <p>CorRECTreatment is an online CDS tool that serves to aid physicians
in the selection of the most appropriate treatment methods for rectal
cancer patients. Additionally, the tool can be used to predict an average overall survival time for the suggested treatment methods.</p>
                        </div>
                        <div class="flex-shrink-0"><span class="text-primary"><a href="https://medinfo.deu.edu.tr/dsrct/">webpage</a></span></div>
                    </div>
                </div>
            </section>
            <hr class="m-0" />
        </div>
        <!-- Bootstrap core JS-->
        <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.1.3/dist/js/bootstrap.bundle.min.js"></script>
        <!-- Core theme JS-->
        <script src="js/scripts.js"></script>
    </body>
</html>
